| |
|
|
|
Cytosorbents Cor  
|
|
8.11 -0.26 (-0.03%) |
10-21 14:23 |
|
Open: |
8.36 |
Pre close: |
8.37 |
Target:
|
10.13
|
|
High: |
8.36 |
Low: |
8.08 |
Resistance:
|
8.67
9.39
|
|
Volume: |
133,465 |
Market Cap: |
350M |
Support:
|
7.51
6.25
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.43
 |
MACD |
MACD(12,26):
|
0.05 |
|
MA(20): |
8.19  |
Signal(12,26,9): |
0.02 |
|
MA(100): |
8.99 |
Stochastic Oscillator |
%K(14,3):
|
41.62 |
|
MA(250): |
7.15 |
%D(3): |
47.40 |
|
Average Volume(K) |
3-Month: |
36000
|
52-Week |
High:
|
11.74 |
|
10-Days: |
23988 |
Low: |
3.49 |
|
RSI |
RSI(14):
|
47.32 |
Change(%): |
69.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.510 |
Return on Equity (ttm) |
-95.7 |
Shares Out. (M) |
43.16 |
|
EPS Est. Current Year |
-0.270 |
Return on Assets (ttm) |
-27.1 |
Shares Float (M) |
39.55 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.27 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
57.2 |
% Held by Institutions |
26.73 |
|
Forward EPS |
-0.600 |
Gross Profit (p.s.) |
0.408 |
Shares Short (K) |
2900 |
|
Book Value (p.s.) |
0.660 |
EBITDA (p.s.) |
-0.375 |
P/E |
-16.04 |
|
Sales Per Share |
0.742 |
Qtrly Earnings Growth |
0.00 |
P/BV |
12.39 |
|
Profit Margin |
-53.56 |
Operating Cash Flow
(M) |
-10.60 |
P/S |
11.02 |
|
Operating Margin |
-52.56 |
Levered Free Cash Flow
(M) |
-6.91 |
P/CF |
-33.31 |
|
|
|
|
|
|
